HAWTHORNE, N.Y.--(BUSINESS WIRE)--July 18, 2006--Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," NASDAQ: TARO) today announced that it is in the last stages of completing the audit of its financial statements for the year ended December 31, 2005. Taro said it anticipates completion of the audit next month.
